177 related articles for article (PubMed ID: 18827906)
21. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
[TBL] [Abstract][Full Text] [Related]
22. Treating the diseased superficial femoral artery.
Gibbs JM; Peña CS; Benenati JF
Tech Vasc Interv Radiol; 2010 Mar; 13(1):37-42. PubMed ID: 20123431
[TBL] [Abstract][Full Text] [Related]
23. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ;
J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459
[TBL] [Abstract][Full Text] [Related]
24. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
Donas KP; Schwindt A; Schönefeld T; Tessarek J; Torsello G
Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
[TBL] [Abstract][Full Text] [Related]
25. Femoropopliteal in-stent restenosis: review and potential for drug based therapy.
Phillips J; Ansel G
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):333-6. PubMed ID: 23640356
[TBL] [Abstract][Full Text] [Related]
26. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.
Duda SH; Pusich B; Richter G; Landwehr P; Oliva VL; Tielbeek A; Wiesinger B; Hak JB; Tielemans H; Ziemer G; Cristea E; Lansky A; Bérégi JP
J Invasive Cardiol; 2004 Jan; 16 Suppl A():15A-19A. PubMed ID: 23573600
[TBL] [Abstract][Full Text] [Related]
27. Transpopliteal stenting of femoral occlusions in patients with critical limb ischemia using a 4-French system.
Spreen M; Vink T; Knippenberg B; Reekers J; van Dijk L; Wever J; van Eps R; van Overhagen H
Cardiovasc Intervent Radiol; 2014 Aug; 37(4):908-13. PubMed ID: 24722899
[TBL] [Abstract][Full Text] [Related]
28. [Stents in peripheral arterial occlusive diseases (PAOD)].
Roeren T
Ther Umsch; 2003 Apr; 60(4):199-203. PubMed ID: 12731429
[TBL] [Abstract][Full Text] [Related]
29. Predictors of failure of endovascular therapy for peripheral arterial disease.
Yacyshyn VJ; Thatipelli MR; Lennon RJ; Bailey KR; Stanson AW; Holmes DR; Gloviczki P
Angiology; 2006; 57(4):403-17. PubMed ID: 17022375
[TBL] [Abstract][Full Text] [Related]
30. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies.
Langwieser N; Buyer D; Schuster T; Haller B; Laugwitz KL; Ibrahim T
J Endovasc Ther; 2014 Oct; 21(5):683-92. PubMed ID: 25290797
[TBL] [Abstract][Full Text] [Related]
31. Infrapopliteal stents: overview and unresolved issues.
Karnabatidis D; Katsanos K; Siablis D
J Endovasc Ther; 2009 Feb; 16 Suppl 1():I153-62. PubMed ID: 19317574
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in peripheral angioplasty and stenting.
Faries P; Morrissey NJ; Teodorescu V; Gravereaux EC; Burks JA; Carroccio A; Kent KC; Hollier LH; Marin ML
Angiology; 2002; 53(6):617-26. PubMed ID: 12463614
[TBL] [Abstract][Full Text] [Related]
33. Below-the-knee revascularization. Advanced techniques.
SCHWARZWALDER U; ZELLER T
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):627-34. PubMed ID: 19741578
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents.
Antoniou GA; Chalmers N; Kanesalingham K; Antoniou SA; Schiro A; Serracino-Inglott F; Smyth JV; Murray D
J Endovasc Ther; 2013 Apr; 20(2):131-44. PubMed ID: 23581752
[TBL] [Abstract][Full Text] [Related]
35. Stenting in the femoropopliteal arterial segment.
Mewissen MW
Tech Vasc Interv Radiol; 2005 Dec; 8(4):146-9. PubMed ID: 16849093
[TBL] [Abstract][Full Text] [Related]
36. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Dake MD; Ansel GM; Jaff MR; Ohki T; Saxon RR; Smouse HB; Machan LS; Snyder SA; O'Leary EE; Ragheb AO; Zeller T;
Circulation; 2016 Apr; 133(15):1472-83; discussion 1483. PubMed ID: 26969758
[TBL] [Abstract][Full Text] [Related]
37. Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease.
Katsanos K; Spiliopoulos S; Diamantopoulos A; Siablis D; Karnabatidis D; Scheinert D
JACC Cardiovasc Interv; 2016 Feb; 9(3):259-267. PubMed ID: 26777329
[TBL] [Abstract][Full Text] [Related]
38. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
[TBL] [Abstract][Full Text] [Related]
39. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease.
Lammer J; Bosiers M; Zeller T; Schillinger M; Boone E; Zaugg MJ; Verta P; Peng L; Gao X; Schwartz LB
J Vasc Surg; 2011 Aug; 54(2):394-401. PubMed ID: 21658885
[TBL] [Abstract][Full Text] [Related]
40. How to interpret data from the superficial femoral artery stenting trials and registries.
Lin PH; Weakley SM; Kougias P
Semin Vasc Surg; 2010 Sep; 23(3):138-47. PubMed ID: 20826290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
